Pantoprazole Mylan (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazole Mylan, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Pantoprazole Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole Mylan is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): improves symptom relief and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates healing of erosive lesions. - Zollinger‑Ellison syndrome: controls gastric acid hyper‑secretion. - Prevention of gastric ulcer risk in high‑risk patients who receive non‑steroidal anti‑inflammatory drugs (NSAIDs). - Healing of peptic ulcer disease including duoden and gastric ulcers. - Maintenance of healed erosive esophagitis to prevent relapse of symptoms and lesions.